SEC Comment Letter for ClearPoint Neuro, (CLPT) — Jan 27, 2026
ClearPoint Neuro, Inc.
Date: Jan. 27, 2026 · CIK: 0001285550 · Accession: 0000000000-26-000837
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292733
Letter
Re: ClearPoint Neuro, Inc. Registration Statement on Form S-3 Filed January 14, 2026 File No. 333-292733 Dear Joseph Burnett:
January 20, 2026
Joseph Burnett Chief Executive Officer ClearPoint Neuro, Inc. 120 S. Sierra Ave. Suite 100 Solana Beach, CA 92075
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and Services
cc: John Tishler
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> January 20, 2026 Joseph Burnett Chief Executive Officer ClearPoint Neuro, Inc. 120 S. Sierra Ave. Suite 100 Solana Beach, CA 92075 Re: ClearPoint Neuro, Inc. Registration Statement on Form S-3 Filed January 14, 2026 File No. 333-292733 Dear Joseph Burnett: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: John Tishler </TEXT> </DOCUMENT>